this invention relates to a sustained release pharmaceutical composition comprising at least a cephalosporin antibiotic , a mixture of polymers and other pharmaceutically acceptable excipients ; in the composition , polymers are selected from mixture of galactomannans and neutral swellable polymers , which releases the active ingredient in a predetermined manner .